DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

The Effect of Clonidine in Glycemia During Coronary Artery Bypass Graft With Cardiopulmonary By-pass

Information source: Federal University of Juiz de Fora
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Glycemia During Coronary Artery Bypass Graft; Sedation During Pre-anesthetic Medication

Intervention: Clonidine (Drug); Ringer lactato (Drug)

Phase: Phase 4

Status: Completed

Sponsored by: Federal University of Juiz de Fora


The purpose of this study is the randomized blind research of the assessment of the different levels of glycemia during Coronary Artery Bypass Graft (CABG) with cardiopulmonary by-pass (CPB) between clonidine and placebo. As clonidine decrease the inflammatory response during cardiac surgery, the investigators would like to know if the glycemia levels in clondine group will be lower than placebo group.

Clinical Details

Official title: The Effect of Clonidine in Glycemia During Coronary Artery Bypass Graft With Cardiopulmonary By-pass.

Study design: Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment

Primary outcome: sedation

Secondary outcome: Glycemia


Minimum age: 45 Years. Maximum age: 80 Years. Gender(s): Both.


Inclusion Criteria:

- elective CABG EF > 40% Sinus ritmy

Exclusion Criteria:

- precordialgia emergency surgery combinated surgery not agreement

Locations and Contacts

National institut of Cardiology, Rio de Janeiro, RJ 3600/100, Brazil
Additional Information

Starting date: January 2011
Last updated: June 13, 2012

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017